Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma

Purpose: To compare efficacy and safety of dual docetaxel/nedaplatin treatment versus docetaxel alone as second-line chemotherapy for advanced esophageal cancer. Methods: In all, 36 patients with metastatic and/or recurrent esophagus squamous cell carcinoma resistant to first-line chemotherapy (fluo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yajima, Satoshi, Suzuki, Takashi, Nanami, Tatsuki, Oshima, Yoko, Kikuchi, Yoshinori, Funahashi, Kimihiko, Shimada, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374090/
https://www.ncbi.nlm.nih.gov/pubmed/33408308
http://dx.doi.org/10.5761/atcs.oa.20-00294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374090/
https://www.ncbi.nlm.nih.gov/pubmed/33408308
http://dx.doi.org/10.5761/atcs.oa.20-00294

Ejemplares similares